Bio-Sig-Logo-horiz.jpg
BioSig Technologies, Inc. Issues Shareholder Letter with Corporate Update on Recent Achievements
May 11, 2022 08:30 ET | BioSig Technologies, Inc.
Westport, CT, May 11, 2022 (GLOBE NEWSWIRE) -- To date, Company's FDA 510(k) cleared PURE EP(TM) system has completed over 2,200 patient cases with 75 physicians at 17 hospitals across the...
Bio-Sig-Logo-horiz.jpg
BioSig to Present at Heart Rhythm 2022
April 19, 2022 09:10 ET | BioSig Technologies, Inc.
Westport, CT, April 19, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
Bio-Sig-Logo-horiz.jpg
BioSig to Present at NobleCon18 Capital Markets Conference
April 07, 2022 08:30 ET | BioSig Technologies, Inc.
Westport, CT, April 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig Technologies, Inc. Partners with Summit Blue Capital to Provide Equipment Leasing Services
March 29, 2022 10:06 ET | BioSig Technologies, Inc.
Westport, CT, March 29, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Closing of Public Offering of Common Stock
March 23, 2022 08:00 ET | BioSig Technologies, Inc.
Westport, CT, March 23, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig Technologies, Inc. Announces $3 Million Financing with Family Office
March 22, 2022 08:00 ET | BioSig Technologies, Inc.
Westport, CT, March 22, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig Technologies, Inc. Appoints John Sieckhaus as Chief Operating Officer
March 16, 2022 09:00 ET | BioSig Technologies, Inc.
Westport, CT, March 16, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig Awarded US Patent Claims for its PURE EP™ Noise-Filtering Technology
January 26, 2022 13:00 ET | BioSig Technologies, Inc.
Westport, CT, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Claims address computer-implemented systems and methods for filtering noise from input cardiac signals using its PURE EP™ technologyThe Company now...
Bio-Sig-Logo-horiz.jpg
BioSig to Present at the 27th Annual International AF Symposium
January 07, 2022 10:20 ET | BioSig Technologies, Inc.
Westport, CT, Jan. 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig to Present at the 24th Annual Virtual Needham Growth Conference
January 06, 2022 08:30 ET | BioSig Technologies, Inc.
Westport, CT, Jan. 06, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...